Detailed information for compound 1491441

Basic information

Technical information
  • TDR Targets ID: 1491441
  • Name: 5-phenyl-1H-pyrazol-3-amine
  • MW: 159.188 | Formula: C9H9N3
  • H donors: 2 H acceptors: 1 LogP: 1.53 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: Nc1[nH]nc(c1)c1ccccc1
  • InChi: 1S/C9H9N3/c10-9-6-8(11-12-9)7-4-2-1-3-5-7/h1-6H,(H3,10,11,12)
  • InChiKey: PWSZRRFDVPMZGM-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (5-phenyl-1H-pyrazol-3-yl)amine
  • 827-41-8
  • 1572-10-7
  • SBB005555
  • 3-Phenyl-1H-pyrazol-5-amine
  • Maybridge1_004361
  • ZINC00154772
  • 5-Amino-3-phenylpyrazole
  • ST5210444
  • GL-0701
  • ZINC03887184
  • 1H-Pyrazol-3-amine, 5-phenyl-
  • 3-Amino-5-phenylpyrazole
  • 4-25-00-02617 (Beilstein Handbook Reference)
  • BRN 0004947
  • Pyrazole, 5-amino-3-phenyl-
  • 393797_ALDRICH

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica pyruvate:ferredoxin oxidoreductase 0.0049 0.004 0.5
Toxoplasma gondii thioredoxin reductase 0.0048 0 0.5
Trypanosoma brucei phosphonopyruvate decarboxylase-like protein, putative 0.0109 0.2112 1
Mycobacterium ulcerans pyruvate or indole-3-pyruvate decarboxylase Pdc 0.0192 0.5014 0.4994
Trypanosoma cruzi phosphonopyruvate decarboxylase, putative 0.0109 0.2112 1
Plasmodium vivax acyl-CoA synthetase, putative 0.0192 0.5014 1
Schistosoma mansoni acetolactate synthase 0.0287 0.8305 1
Mycobacterium tuberculosis Acetolactate synthase (large subunit) IlvB1 (acetohydroxy-acid synthase) 0.0144 0.3331 0.3331
Trichomonas vaginalis pyruvate-flavodoxin oxidoreductase, putative 0.0049 0.004 0.5
Mycobacterium ulcerans hypothetical protein 0.0109 0.2112 0.208
Mycobacterium leprae PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) 0.0336 1 1
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0109 0.212 0.212
Trypanosoma cruzi phosphonopyruvate decarboxylase, putative 0.0109 0.2112 1
Mycobacterium tuberculosis Probable oxidoreductase (beta subunit) 0.0049 0.004 0.004
Mycobacterium ulcerans putative oxalyl-CoA decarboxylase 0.0336 1 1
Echinococcus granulosus geminin 0.0169 0.4208 1
Mycobacterium ulcerans acetolactate synthase 0.0192 0.5014 0.4994
Mycobacterium tuberculosis Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) 0.0336 1 1
Mycobacterium leprae PROBABLE NADH DEHYDROGENASE NDH 0.0109 0.212 0.1778
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0121 0.2541 0.2541
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0109 0.212 0.212
Mycobacterium leprae Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) 0.0336 1 1
Mycobacterium ulcerans acetolactate synthase 1 catalytic subunit 0.0336 1 1
Trichomonas vaginalis pyruvate-flavodoxin oxidoreductase, putative 0.0049 0.004 0.5
Mycobacterium tuberculosis Probable oxalyl-CoA decarboxylase OxcA 0.0336 1 1
Mycobacterium ulcerans acetolactate synthase large subunit IlvB 0.0192 0.5014 0.4994
Mycobacterium ulcerans 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase 0.006 0.0417 0.0378
Trichomonas vaginalis pyruvate-flavodoxin oxidoreductase, putative 0.0049 0.004 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0121 0.2541 0.2541
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0121 0.2541 0.2217
Trichomonas vaginalis pyruvate-flavodoxin oxidoreductase, putative 0.0049 0.004 0.5
Trichomonas vaginalis pyruvate-flavodoxin oxidoreductase, putative 0.0049 0.004 0.5
Schistosoma mansoni acetolactate synthase 0.0287 0.8305 1
Trichomonas vaginalis pyruvate-flavodoxin oxidoreductase, putative 0.0049 0.004 0.5
Schistosoma mansoni hypothetical protein 0.0169 0.4208 0.1249
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0109 0.212 0.212
Loa Loa (eye worm) ILVBL protein 0.0203 0.5402 1
Mycobacterium ulcerans hypothetical protein 0.0336 1 1
Schistosoma mansoni hypothetical protein 0.0169 0.4208 0.1249
Loa Loa (eye worm) thiamine pyrophosphate enzyme 0.0192 0.5026 0.9303
Trypanosoma brucei phosphonopyruvate decarboxylase-like protein, putative 0.0109 0.2112 1
Treponema pallidum pyruvate oxidoreductase 0.0049 0.004 0.5
Leishmania major phosphonopyruvate decarboxylase-like protein 0.0109 0.2112 0.4212
Giardia lamblia Pyruvate-flavodoxin oxidoreductase 0.0049 0.004 0.5
Mycobacterium tuberculosis Probable reductase 0.0109 0.212 0.212
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0109 0.212 0.212
Echinococcus multilocularis geminin 0.0169 0.4208 1
Mycobacterium tuberculosis Probable dehydrogenase 0.0109 0.212 0.212
Leishmania major putative pyruvate/indole-pyruvate carboxylase, putative 0.0192 0.5014 1
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0121 0.2541 0.2541
Plasmodium falciparum acyl-CoA synthetase 0.0192 0.5014 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.